Name That Brand: November 2012

Share this article:

Can you name the brand? Each month we print part of a popular pharmaceutical product or advertisement, with clues to its identity. Readers are invited to name the brand for a chance to win a copy of Medicine Avenue II. E-mail your answer to NameThatBrand@haymarketmedia.com or fax 646-638-6150. The deadline is November 30, 2012. The winner will be picked randomly from all correct entries.

Brand X targets many populations
The sign is familiar, but identifying which audience it's meant to resonate with isn't so simple. After all, this brand isn't content with one crowd. This drug is being considered for new indications, which, if approved, could mean shelf space for at least 12 discrete patient populations. The drug maker is so confident that execs brushed off patent expiration worries during a recent earnings call, and said they believe this cornerstone product will continue to wow the marketplace.

SEPTEMBER'S WINNER...
Erin Hicks, product manager at ViiV Healthcare, correctly identified an ad for Takeda's Actos, a prescription medication used to improve blood sugar (glucose) control in adults with type 2 diabetes.
Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Antidote: On Cystic Fibrosis treatments

Antidote: On Cystic Fibrosis treatments

Recent treatments in CF, including the inhaled antibiotic Tobramycin, have increased lifespan well into adulthood.

The $3 generic and the $1,000 pill: pharma outsiders just don't get it

The $3 generic and the $1,000 pill: pharma ...

What do you call the people who treat medical breakthroughs as if they were bank heists? Malicious? Uninformed? Not with it?

Leadership Exchange Uncut : The Agency-Client Relationship

Leadership Exchange Uncut : The Agency-Client Relationship

Click the above link to access MM&M's first Leadership Exchange Uncut e-book, "The Agency-Client Relationship"